Loading organizations...
Loading organizations...
Clinical-stage company developing novel cancer therapies.
Lupeng Pharmaceutical has raised $70.0M across 2 funding rounds.
Lupeng Pharmaceutical has raised $70.0M in total across 2 funding rounds.
Lupeng Pharmaceutical has raised $70.0M in total across 2 funding rounds.
Lupeng Pharmaceutical's investors include Temasek, Fontus Capital, Kaitai Capital, Bin Li, Lilly Asia Ventures, TF Capital.
Lupeng Pharmaceutical has raised $70.0M across 2 funding rounds. Most recently, it raised $35.0M Pre-Series B in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 16, 2022 | $35.0M Pre-Series B | ||
| Jul 28, 2021 | $35.0M Pre-Series B | Temasek | Fontus Capital, Kaitai Capital, Bin Li, Lilly Asia Ventures, TF Capital |